← Kalshi

Which peptides will the FDA propose adding to the 503A Bulks List?

Open

Before Oct 1, 2027

Selected outcome

Semax

76%

Semax · 76%

Stored quote · checking the venue

Scheduled end
Sep 30, 2027 ET
Resolution source
U.S. Food and Drug Administration (opens in a new tab)

Price

Loading price history.

Markets

  • BPC-157

    Will the U.S. Food and Drug Administration announce publication of a proposed rule that would add BPC-157 (free base) or BPC-157 acetate to the 503A Bulks List before Oct 1, 2027?

    75%

    Open · ~$0 24h · ~$132 vol

    Bid 72¢ · Ask 78¢

    Open full market view →
  • Emideltide

    Will the U.S. Food and Drug Administration announce publication of a proposed rule that would add emideltide (free base) or emideltide acetate to the 503A Bulks List before Oct 1, 2027?

    25%

    Open · ~$0 24h · ~$2 vol

    Bid 22¢ · Ask 28¢

    Open full market view →
  • Epitalon

    Will the U.S. Food and Drug Administration announce publication of a proposed rule that would add Epitalon (free base) or Epitalon acetate to the 503A Bulks List before Oct 1, 2027?

    76%

    Open · ~$0 24h · ~$60 vol

    Bid 72¢ · Ask 79¢

    Open full market view →
  • KPV

    Will the U.S. Food and Drug Administration announce publication of a proposed rule that would add KPV (free base) or KPV acetate to the 503A Bulks List before Oct 1, 2027?

    75%

    Open · ~$0 24h · ~$765 vol

    Bid 72¢ · Ask 78¢

    Open full market view →
  • MOTS-c

    Will the U.S. Food and Drug Administration announce publication of a proposed rule that would add MOTS-c (free base) or MOTS-c acetate to the 503A Bulks List before Oct 1, 2027?

    76%

    Open · ~$0 24h · ~$139 vol

    Bid 72¢ · Ask 79¢

    Open full market view →
  • Semax

    Will the U.S. Food and Drug Administration announce publication of a proposed rule that would add Semax (free base) or Semax acetate to the 503A Bulks List before Oct 1, 2027?

    76%

    Open · ~$0 24h · ~$60 vol

    Bid 72¢ · Ask 79¢

    Open full market view →
  • TB-500

    Will the U.S. Food and Drug Administration announce publication of a proposed rule that would add TB-500 (free base) or TB-500 acetate to the 503A Bulks List before Oct 1, 2027?

    76%

    Open · ~$0 24h · ~$161 vol

    Bid 72¢ · Ask 79¢

    Open full market view →
Event statistics
24h vol
~$0
Volume
~$1,319
Liquidity
—
Open int.
1,090 contracts

How this resolves

Scheduled end
Sep 30, 2027 ET
  1. Trading
  2. Closed
  3. In review
  4. Resolved
Rules text

If the U.S. Food and Drug Administration announces publication of a proposed rule that would add Semax (free base) or Semax acetate to the 503A Bulks List before Oct 1, 2027, then the market resolves to Yes.

View on Kalshi